Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apollomics | APLM | Jan 15, 2025 | 9.92 | -1.98 |
AppFolio A | APPF | Jan 15, 2025 | 252.49 | +2.40 |
Appian A | APPN | Jan 15, 2025 | 33.45 | +3.24 |
Apple | AAPL | Jan 15, 2025 | 237.87 | +1.97 |
Apple Hospitality REIT | APLE | Jan 15, 2025 | 15.16 | +2.16 |
Applied Digital | APLD | Jan 15, 2025 | 8.37 | -1.99 |
Applied DNA Sciences | APDN | Jan 15, 2025 | 0.20 | +7.95 |
Applied Industrial Technologies | AIT | Jan 15, 2025 | 253.10 | -0.09 |
Applied Materials | AMAT | Jan 15, 2025 | 178.38 | +2.72 |
Applied Optoelectronics | AAOI | Jan 15, 2025 | 31.18 | +12.20 |
Applied Therapeutics | APLT | Jan 15, 2025 | 0.66 | +3.03 |
Applovin A | APP | Jan 15, 2025 | 335.03 | +4.34 |
AppTech Payments | APCX | Jan 15, 2025 | 0.48 | +4.45 |
Aprea Therapeutics | APRE | Jan 15, 2025 | 3.67 | +1.38 |
AptarGroup | ATR | Jan 15, 2025 | 155.56 | +0.61 |
Aptevo Therapeutics | APVO | Jan 15, 2025 | 4.55 | 0.00 |
Aptiv | APTV | Jan 15, 2025 | 60.89 | -0.94 |
Aptorum Group A | APM | Jan 15, 2025 | 1.23 | 0.00 |
Aptose Biosciences | APTO | Jan 15, 2025 | 0.21 | +1.53 |
APx Acquisition I Unit | APXIU | Jan 15, 2025 | 11.55 | 0.00 |
Apyx Medical | APYX | Jan 15, 2025 | 1.42 | -0.70 |
Aqua Metals | AQMS | Jan 15, 2025 | 2.07 | +0.49 |
AquaBounty Technologies | AQB | Jan 15, 2025 | 0.76 | -1.34 |
Aquaron Acquisition | AQU | Jan 15, 2025 | 12.04 | 0.00 |
Aquaron Acquisition Units | AQUNU | Jan 15, 2025 | 11.95 | 0.00 |
Aquestive Therapeutics | AQST | Jan 15, 2025 | 3.24 | +6.23 |
Aramark | ARMK | Jan 15, 2025 | 39.27 | +2.75 |
ARB IOT Group | ARBB | Jan 15, 2025 | 0.56 | -0.71 |
Arbe Robotics | ARBE | Jan 15, 2025 | 3.27 | +9.00 |
Arbor Realty Trust | ABR | Jan 15, 2025 | 13.63 | +2.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.